Recent Advances in Combination of Immunotherapy and Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma

SIMPLE SUMMARY: Neoadjuvant chemoradiotherapy (CRT), followed by surgery or definitive CRT, is the standard treatment for locally advanced esophageal squamous cell carcinoma (ESCC); however, the clinical outcomes remain unsatisfactory. Immunotherapy combined with CRT is currently being investigated...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ruixi, Liu, Shiliang, Chen, Baoqing, Xi, Mian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599968/
https://www.ncbi.nlm.nih.gov/pubmed/36291954
http://dx.doi.org/10.3390/cancers14205168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599968/
https://www.ncbi.nlm.nih.gov/pubmed/36291954
http://dx.doi.org/10.3390/cancers14205168

Ejemplares similares